Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
100.00
-1.50 (-1.48%)
Apr 2, 2025, 1:30 PM CST

Gongwin Biopharm Holdings Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
12,66014,36920,91136,13231,10426,551
Upgrade
Market Cap Growth
-31.28%-31.28%-42.13%16.16%17.15%222.07%
Upgrade
Enterprise Value
10,39112,19420,03635,49830,38326,037
Upgrade
Last Close Price
100.00113.50184.50319.50279.64240.11
Upgrade
PS Ratio
448.48448.481105.5031611.2427212.5931874.31
Upgrade
PB Ratio
4.164.6415.9426.3131.5023.74
Upgrade
P/TBV Ratio
4.634.6315.9025.9632.0424.29
Upgrade
EV/Sales Ratio
380.58380.581059.2631056.7426581.6831256.89
Upgrade
Debt / Equity Ratio
0.040.040.060.100.120.03
Upgrade
Asset Turnover
0.010.010.010.000.000.00
Upgrade
Inventory Turnover
3.013.011.27---
Upgrade
Quick Ratio
13.2713.277.585.805.3418.67
Upgrade
Current Ratio
13.3613.368.866.995.9519.05
Upgrade
Return on Equity (ROE)
-4.17%-4.17%-7.54%-24.75%-12.34%-10.95%
Upgrade
Return on Assets (ROA)
-4.14%-4.14%-5.31%-11.66%-6.36%-7.41%
Upgrade
Return on Capital (ROIC)
-4.39%-4.39%-5.74%-12.45%-6.69%-7.83%
Upgrade
Earnings Yield
-0.65%-0.57%-0.48%-0.81%-0.39%-0.35%
Upgrade
FCF Yield
-2.32%-2.04%-0.53%-0.66%-0.70%-0.44%
Upgrade
Buyback Yield / Dilution
-6.84%-7.17%-1.92%-1.44%-4.87%-1.37%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.